CD19 - Globe Thesis - Globe Thesis

Keyword [CD19] Result: 121 - 140 \| Page: 7 of 9
121.	Antibody Coengagement Of FcγRIIB And CD19 (XmAb5871) Induces Specific Chromatin And Gene Expression Changes Linked To The Key B Lineage Transcription Factors In IgG4-related Disease
122.	Study On The Effect And Mechanism Of IL-7 Promoting CD19-directed CAR-T Cells Proliferation
123.	Study Of T-cell Subsets In Peripheral Blood Of B-cell Acute Lymphoblastic Leukemia Patients And Their Effect On CD19 CAR-T Cell Therapy
124.	Clinical Study On Donor-derived Targeting CD19 CAR-T Cells For The Treatment Of Relapsed CD19~+ B-cell Acute Lymphoblastic Leukemia After Hematopoietic Stem Cell Transplantation
125.	Investigation Of The Clinical And Immunological Characteristic Of Ezcematous Psoriasis
126.	High CD21 Expression Inhibits CAR T Cells Targeting CD19 Eliminate Lymphoma Cells
127.	Toxicities And Relative Factors Of CD19 Targeted Chimeric Antigen Receptor T Cell Therapy In Relapse/refractory B-cell Hematological Malignancies
128.	Effect And Mechanism Of Regulatory B Cells In Inflammatory Bowel Disease
129.	The Role Of CD95 Signaling In EBV-associated Lymphoproliferative Diseases
130.	Analysis Of Treatment And Prognosis For 20 Patients With Anti-γ-aminobutyric Acid B Receptor Encephalitis
131.	Clinical Study Of Targeting CD19 Fourth-generation Chimeric Antigen Receptor T Cells In Treating Relapsed Or Refractory B Cell Non-hodgkin Lymphoma
132.	Hematologic Toxicity And Kinetics Of Immune Function And Relevant Factors Analysis After Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory Acute B Lymphoblastic Leukemia
133.	Study On The Prognosis Evaluation And Treatment Strategy Of Acute Leukemia
134.	A Study Of Infections Of R/R B-ALL Patients After Treated With Sequential Infusion Of Anti-CD19 And Anti-CD22 CAR T-cells
135.	Study On The Preparation And Function Of PD-L1 Single-chain Antibody Secretory CAR-T
136.	A Clinical Study Of Fourth-generation CD19-CAR T-cells In The Threapy Of Relapsed/Refractory Adult Acute B Lymphocytic Leukemia
137.	Anti-CD19 MAb Modified Mesoporous Titanium Dioxide As Targeting Vector For B-lymphoblastic Leukemia Therapy
138.	The Establishment And Application Of EBV Quantitative Detection Method In Thymoma
139.	Clinical Observation On The Treatment Of Henoch-Schoniein Purpura Nephritis By Stage With Traditional Chinese Medicine
140.	Construction Of Camelidae Natural Nanobody Phage Dispaly Library And Screening For Anti-CD19 Nanobody And Verification
<<First <Prev Next> Last>> Jump to